BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

“Outdated protocols” and a lack of patient education around anaphylaxis treatment can result in poor patient outcomes, Medscape Medical News reported Oct. 28. A survey of 96 patients and caregivers ...

An international panel of experts has developed standardized definitions and treatment protocols for anaphylaxis, aiming to eliminate long-standing inconsistencies in emergency care. The Global ...

The new guidelines reflect the efforts of a 46-member panel of experts from 14 countries and seven medical specialties. The findings have received endorsements from 34 medical and patient advocacy ...

Please provide your email address to receive an email when new articles are posted on . Omalizumab may effectively treat idiopathic anaphylaxis in patients without indication of mast cell clonality ...

Neffy, a nasal spray alternative to the EpiPen and similar injectables, has been approved by the FDA. The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has ...

Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and ...

Please provide your email address to receive an email when new articles are posted on . Less than half of physicians identified gastrointestinal and upper respiratory tract symptoms as potential signs ...

Anaphylaxis is a severe, life threatening allergic reaction; but now, there are new recommendations on how to improve treatment. Anaphylaxis can progress quickly and could be deadly if the life-saving ...

neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in adults and children aged 4 years and older who weigh at least 33 pounds (15 kg) ...